Old Republic Q4 EPS misses estimates on commercial auto losses

Reuters
01/22
Old Republic Q4 EPS misses estimates on commercial auto losses

Overview

  • Specialty insurer's Q4 net income rose significantly compared to last year

  • Adjusted EPS for Q4 missed analyst expectations

  • Consolidated net premiums and fees earned increased 9.8% yr/yr

Result Drivers

  • SPECIALTY INSURANCE - Premium rate increases and high renewal retention drove net premiums earned growth, but higher loss ratios in commercial auto affected underwriting income

  • TITLE INSURANCE - Lower interest rates and strong commercial business production boosted net premiums and fees earned

  • CORPORATE & OTHER - Segment faced reduced net investment income and higher operating expenses

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Total operating revenues

$2.36 bln

Q4 Adjusted EPS

Miss

$0.74

$0.88 (3 Analysts)

Q4 Net Income

$206.30 mln

Q4 Combined Ratio

96.00%

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the property & casualty insurance peer group is "buy"

  • Wall Street's median 12-month price target for Old Republic International Corp is $49.00, about 13.6% above its January 21 closing price of $43.12

  • The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release: ID:nPnbv6Bb5a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10